Linesider
Device Thoracolumbar spine
General payments
$733,732
Research payments
$0
Through program year 2024, $733,732 in general payments and $0 in research payments were reported against Linesider (Thoracolumbar spine).
No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.
By program year
6 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2024 | General | $213,081 | 80 |
| 2023 | General | $139,014 | 38 |
| 2022 | General | $169,226 | 55 |
| 2021 | General | $154,333 | 78 |
| 2020 | General | $23,990 | 54 |
| 2019 | General | $34,089 | 90 |
Breakdown
The top 5 of 18 recipients; each share is of general payments naming this product in 2024.
Each share is of general payments naming this product to practitioners with a specialty in 2024. Each practitioner is counted under their primary specialty.
The top 5 of 7 states; each share is of general payments naming this product in 2024 where a state was reported.
Records
395 generalEvery payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
What you are looking at
Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.